Clinical Trial Update: A Pilot Study of Biomarkers for Spinal Muscular Atrophy

View source ↗

Summary

This update reports the completion of a pilot clinical trial evaluating biomarkers for Spinal Muscular Atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Snippet

Sponsor: Carelon Research | Conditions: Spinal Muscular Atrophy | Status: COMPLETED